
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer. Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.81 | -10.6358819076 | 26.42 | 27.28 | 23.53 | 554982 | 25.14709801 | CS |
4 | -0.56 | -2.31692180389 | 24.17 | 27.28 | 23.05 | 854352 | 24.81234463 | CS |
12 | -8.11 | -25.5674653216 | 31.72 | 33.97 | 22.48 | 984763 | 26.66446953 | CS |
26 | -37.22 | -61.1869143515 | 60.83 | 62.3 | 22.48 | 951345 | 34.0996519 | CS |
52 | -19.08 | -44.6943078004 | 42.69 | 71.71 | 22.48 | 858775 | 41.28373302 | CS |
156 | 12.15 | 106.020942408 | 11.46 | 71.71 | 5.65 | 458990 | 39.26102413 | CS |
260 | -10.39 | -30.5588235294 | 34 | 71.71 | 5.65 | 377520 | 37.68762019 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions